CareASSIST is here to help you get the information and support you need. In addition to the program offerings, you may also find the following downloads and online resources helpful.
The CareASSIST application covers all aspects of the program: Access and Reimbursement, Financial Assistance, and Resource Support. Follow the directions on the form to apply, or call 1-833-WE+CARE to get started.
The CareASSIST brochure contains an overview of the program and its offerings.
An overview of potential sources of prescription assistance.
Certain patients may require information or assistance beyond what CareASSIST may offer. Below are links to external organizations that may be able to help, or you can call 1-833-WE+CARE to learn about alternate coverage options.
Learn about Medicaid in your state and if you may be eligible.
Learn about Medicare and prescription drug coverage, eligibility, and how to access the care you may need.
Find help for insurance and healthcare access problems.
Offers help and hope to people with chronic or life-threatening illnesses for whom cost limits access to breakthrough medical treatments.
American Cancer Society—MM
American Cancer Society—NHL
The American Cancer Society’s mission is to save lives, celebrate lives, and lead the fight for a world without cancer.
Dedicated to providing transplant patients, survivors, and their loved ones with emotional support and high-quality, easy-to-understand information about bone marrow, peripheral blood stem cell, and cord blood transplants.
Offers financial assistance and free support services to bone marrow/stem cell transplant patients and their families.
Dedicated to improving survival, treatment, and quality of life for transplant patients. With more than 1100 publications, the CIBMTR conducts practice-changing research that helps patients and physicians.
The first and largest myeloma-specific charity in the world. With more than 525,000 members in 140 countries, the IMF serves myeloma patients, family members, and the medical community. The IMF provides a wide range of programs in the areas of research, education, support, and advocacy.
The mission of The Leukemia & Lymphoma Society (LLS) is: cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS exists to find cures and ensure access to treatments for blood cancer patients. The LLS is the voice for all blood cancer patients, and works to ensure access to treatments for all blood cancer patients.
The nation’s largest lymphoma-focused health organization devoted to improving care through education and support services and improving outcomes through investment in the most promising lymphoma research. Our mission is to eradicate lymphoma and serve all those impacted by this blood cancer.
Because its only motivation is to find a cure, it is unencumbered in its ability to identify the barriers to progress, develop models to overcome them, and help evolve the industry through technologies that foster collaboration and leverage the collective power of the entire community.
Independent, up-to-date news and information for the multiple myeloma community.
Dedicated to helping individuals and their families from diagnosis through survivorship. It works with hospitals, cancer centers, and other organizations to reinforce and complement medical care. The nbmtLINK has been linking, curing, and caring since 1992, providing a number of services and resources designed to meet the needs of patients, survivors, caregivers, and health professionals around the country.
Dedicated to helping every patient get the life-saving transplant they need. As a trusted leader in advancing treatments for those facing life-threatening blood cancers, it provides the groundbreaking research, innovative technology, patient support, and education that saves lives.
MOZOBIL® (plerixafor injection) is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) and multiple myeloma (MM).